Report : A-Z CDF items in Formulary 17/04/2021 12:12:15
[
Back
]
Section
Status
CDF
Name
08.01.01
Restricted Use
Bendamustine
08.01.05
Restricted Use
Bevacizumab Avastin
®
08.01.05
Restricted Use
Bortezomib Velcade
®
08.01.05
Restricted Use
Bosutinib Bosulif
®
08.01.05
Restricted Use
Dasatinib Sprycel
®
08.01.05
Restricted Use
Ibrutinib Imbruvica
®
08.01.05
Restricted Use
Ixazomib Ninralo
®
08.01.05
Restricted Use
Larotrectinib 20mg/mL oral solution Vitrakvi
®
08.02.04
Restricted Use
Lenalidomide Revlimid
®
08.01.05
Restricted Use
Neratinib Nerlynx
®
08.01.05
Restricted Use
Osimertinib mesylate Tagrisso
®
08.01.05
Restricted Use
Panitumumab infusion Vectibix
®
08.01.05
Restricted Use
Pertuzumab Perjeta
®
08.01.05
Restricted Use
Ribociclib Kisqali
®
08.01.05
Restricted Use
Ruxolitinib Jakavi
®
08.01.05
Restricted Use
Venetoclax
Joint Medicines Formulary